Liminatus Pharma, Inc. · NASDAQ:LIMN

Samda Biolab Co., Ltd. reported a 5.10% stake in Liminatus Pharma, Inc. (Schedule 13G)

Event Jul 2, 2026 · Filed Jul 22, 2026

Samda Biolab Co., Ltd. reported a 5.10% stake in Liminatus Pharma, Inc., 3,426,548 shares, as a passive investor on Jul 2, 2026. Filed Jul 22, 2026 (Schedule 13G).

Stake
5.10%
Shares
3,426,548
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Samda Biolab Co., Ltd.5.10%3,426,548

Source

View original at SEC

Related